<DOC>
	<DOCNO>NCT02833207</DOCNO>
	<brief_summary>The grow population obese adult predict create large public health burden next decade . This study examine function small blood vessel provide blood flow skeletal muscle , test young obese individual ( &lt; 40 year old , BMI &gt; 30 ) already display reduction blood vessel function . This study test signal blood vessel use increase blood flow change subject . Findings study may help create treatment delay prevent negative effect obesity vascular health .</brief_summary>
	<brief_title>Peripheral Vasodilation Obese Humans</brief_title>
	<detailed_description>The grow population obese adult predict create large public health burden next decade . Obese human also exhibit reduced exercise capacity lower muscle blood flow . The overall goal research program investigate obesity-related change microvascular function contribute impaired muscle blood flow . This proposal seek directly test vascular control human skeletal muscle resistance artery exercise human . The investigator propose study young obese adult , without confound effect age , metabolic syndrome , diabetes-before negative effect obesity exert full negative impact . The general hypothesis endothelium dependent dilation ( EDD ) functional ( exercise ) vasodilation impair via shift away nitric oxide bioavailability shift toward increased reliance potassium ( K+ ) mediate vasodilation . Primary objective To determine whether role K+ mediate vasodilation differs lean obese adult . Aims Aim 1 : To test hypothesis obesity induce endothelial phenotype change create environment EDD exercise dysfunction . The investigator propose obesity alters endothelial enzyme , help explain mechanistic change vasodilation . Aim 2 : To test hypothesis obesity elicits alter endothelial-dependent ( EDD ) functional vasodilation due alter functional potassium channel signal . The investigator propose potassium ( K+ ) channel function account unexplained difference EDD functional vasodilation . More specifically , investigator hypothesize inhibition K+ mediate hyperpolarization ( Inward Rectifying K+ channels-KIR ) identify differential vasodilator mechanism lean obese adult . Study Design Overview Procedures This study design test cardiovascular control clinically healthy human . There 2 separate , scientifically distinct experimental trial conduct lean obese subject : 1 ) EDD 2 ) Rapid Onset Vasodilator ( ROV ) , study immediate increase blood flow onset exercise . Common procedures protocol : After screen determine eligibility , subject visit lab either EDD Rapid Onset Vasodilator ( ROV ) study visit . All pre-screening pre-visit procedure identical . A physician place brachial arterial catheter non-dominant arm local drug infusion . Changes blood flow quantify Doppler ultrasound brachial artery . Monitoring subject hemodynamics ( Heart Rate , Blood Pressure , blood oxygen ) identical . EDD experiment : EDD agonists drug cause vasodilation increase blood flow temporarily . We use 4 different agonist test EDD function several perspective . After control EDD agonist infusion , subject repeat EDD agonist condition K+ channel inhibition , K+ channel plus nitric oxide prostaglandin inhibition . This last phase study aim test acute compensatory/redundant vasodilator mechanism . These trial involve infusion endothelial agonist , without inhibition specific vasodilatory mechanism . Agonists include : ATP , Bradykinin ( BK ) , Isoproterenol ( ISO ) , Acetylcholine ( Ach ) , infuse 3 time ( order randomize ) . Agonists infuse follow condition : 1 ) Alone ( control ) 2 ) combination Barium Chloride ( BaCl2 ) 3 ) combination BaCl2 , L-N-monomethyl Arginine Acetate ( L-NMMA ) , Ketorolac . EDD agonists cause temporary increase forearm blood flow , return baseline within minute infusion stop . Antagonists ( BaCl2 , L-NMMA ketorolac ) likely reduce EDD response agonist , may also reduce rest forearm blood flow increase blood pressure ( e.g . L-NMMA may decrease forearm blood flow 30-50 % increase BP 5-10 mmHg ) . The entire EDD study visit ~5 hour ( 1 hour setup 4 hour experimental procedure ) . The EDD protocol describe : Drugs ( IND approval ) use test basic science vascular function &amp; associate mechanism healthy volunteer . Drugs use improve health condition . Drugs : acetylcholine , isoproterenol , bradykinin , adenosine triphosphate , barium chloride , L-N-monomethyl Arginine Acetate , ketorolac . 1 . 5 minute saline infusion along 2 minute ATP infusion , 2 . 10 minute washout , 3 . 5 minute saline solution along 2 minute BK infusion , 4 . 10 minute washout , 5 . 5 minute saline solution along 2 minute ISO infusion , 6 . 10 minute washout , 7 . 5 minute saline infusion along 2 minute ACh infusion , 8 . 10 minute washout , 9 . 5 minute BaCl2 infusion 2 minute ATP infusion , 10 . 10 minute washout , 11 . 5 minute BaCl2 infusion along 2 minute ACh infusion , 12 . 10 minute washout , 13 . 5 minute BaCl2 infusion along 2 minute ISO infusion , 14 . 10 minute washout , 15 . 5 minute BaCl2 infusion along 2 minute BK infusion , 16 . 10 minute washout , 17 . 10 minute L-NMMA ketorolac infusion ( continuous infusion throughout remainder protocol ) along 5 minute BaCl2 infusion , 2 minute ACh infusion , 18 . 10 minute washout , 19 . 5 minute BaCl2 infusion along 2 minute ISO infusion , 20 . 10 minute washout , 21 . 5 minute BaCl2 infusion along 2 minute ATP infusion , 22 . 10 minute washout , 23 . 5 minute BaCl2 infusion along 2 minute BK infusion . ROV experiment : After control single forearm muscle contraction , subject repeat single contraction condition K+ channel inhibition , K+ channel plus nitric oxide prostaglandin inhibition . This last phase study aim test acute compensatory/redundant vasodilator mechanism . This trial consist three set 6 singular muscle contraction ( three 30 % , three 60 % maximal effort ) , contraction last less 3 second ~90s rest . These single contraction evoke robust ( 100-600 % increase ) rapid ( 3-6 heart beat post contraction ) increase blood flow return normal typically 30 second . This rapid robust response single muscle contraction term `` Rapid Onset Vasodilation '' . 3 minute rest trial allow baseline measurement load inhibitor K+ mediate vasodilation . During 3 min , subject perform single contraction 15 , 30 , 45s 3-min loading/resting period facilitate delivery drug active tissue ( add additional 18 contraction . The first experimental set single contraction complete without drug ( saline control ) . Next , ATP infusion ( exercise ) also use test pharmacological efficacy subsequent inhibitor ( BaCl2 ) . The first ATP infusion perform without drug . Following , second set single contraction conduct infusion BaCl2 . This follow second ATP infusion determine efficacy BaCl2 . The final set single contraction start perform simultaneous infusion three inhibitor ( BaCl2 , L-NMMA , Ketorolac ) . This last phase study aim test acute compensatory/redundant vasodilator mechanism . ROV ( exercise ) study ~4 hour ( 1 hour set 3 hour experimental procedure ) . The ROV protocol describe : Drugs : adenosine triphosphate , barium chloride , L-N-monomethyl Arginine Acetate , ketorolac 1 . 3 muscle contraction 3 minute saline infusion follow 3 additional muscle contraction , 2 . Repeat 3 muscle contraction 3 minute saline infusion follow 3 additional muscle contraction , 3 . 10 minute washout , 4 . Two minute ATP infusion , 5 . 10 minute washout , 6 . 3 muscle contraction 3 minute BaCl2 infusion follow 3 additional muscle contraction , 7 . 3 muscle contraction 3 minute BaCl2 infusion follow 3 additional muscle contraction , 8 . 10 minute washout , 9 . Infusion BaCl2 ( 3 minute ) ATP ( 2 minute ) , 10 . 10 minute washout , 11 . 3 muscle contraction Infusion BaCl2 ( 3 minute ) L-NMMA ketorolac infusion ( 5 minute ) follow 3 additional muscle contraction , 12 . L-NMMA ketorolac infuse throughout remainder protocol low dosage 13 . 3 muscle contraction Infusion BaCl2 ( 3 minute ) L-NMMA ketorolac ( 5 minute ) follow 3 additional muscle contraction .</detailed_description>
	<criteria>Overnight fast No exercise , caffeine , NSAIDS minimum 24 hour Fasting blood glucose &lt; 100 mg/dL Fasting blood cholesterol &lt; 200 mg/dL Fasting blood triglyceride &lt; 150 Blood pressure &lt; 120/80 mmHg ( Lean control ) &lt; 140/90 mmHg ( Obese subject ) Increased risk bleeding , sensitivity lidocaine , procoagulant disorder clot disorder , History cardiovascular , liver , kidney disease , Cardiovascular medication , Smoking history , Vigorous exercise &gt; 60 minute per week , Obstructive sleep apnea , metabolic syndrome , diabetes , Hypertension , Regular use Aspirin NSAIDS ( ( â‰¥5 days/wk ) , Women : breastfeeding , pregnant , premenopausal .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>blood flow</keyword>
	<keyword>vasodilation</keyword>
	<keyword>skeletal muscle</keyword>
	<keyword>Doppler Ultrasound</keyword>
	<keyword>diabetes prevention program</keyword>
	<keyword>endothelium dependent dilation</keyword>
</DOC>